By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CytomX Therapeutics, Inc. 

650 Gateway Boulevard
Suite 125
South San Francisco  California  94080-7014  U.S.A.
Phone: 650-515-4987 Fax: 650-351-0353



Company News
CytomX (CTMX) To Announce First Quarter 2017 Financial Results 4/28/2017 10:47:02 AM
CytomX (CTMX) Appoints Marion McCourt To Board Of Directors 3/30/2017 8:56:57 AM
CytomX (CTMX) Announces Teleconference And Webcast To Provide Corporate Update 3/20/2017 9:03:26 AM
Bay Area's CytomX (CTMX) Surges as Bristol-Myers Squibb (BMY) Signs Up for 8 More Projects With $200 Million Upfront in Deal Totaling $5 Billion 3/20/2017 5:47:05 AM
CytomX Announces Full-Year 2016 Financial Results 3/3/2017 8:48:53 AM
CytomX To Announce Full-Year 2016 Financial Results 3/1/2017 11:18:38 AM
CytomX Announces The First Patient Treated In Phase I/II PROCLAIM-072 Trial 2/2/2017 10:34:20 AM
CytomX Announces U.S. FDA Clearance Of Investigational New Drug Application For Phase I/II Clinical Study Of Anti-PD-L1 Probody Therapeutic, CX-072 12/14/2016 6:54:31 AM
CytomX Announces Selection By Bristol-Myers Squibb (BMY) Of First Clinical Candidate Probody From Collaboration 12/13/2016 7:55:08 AM
CytomX Announces Fourth Target Selection By Bristol-Myers Squibb (BMY) Under Strategic Oncology Collaboration 12/5/2016 8:26:05 AM